Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004699256 | SCV005205522 | uncertain significance | not specified | 2024-06-24 | criteria provided, single submitter | clinical testing | Variant summary: EVC c.2653G>A (p.Asp885Asn) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251260 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.2653G>A in individuals affected with Ellis-van Creveld syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 990328). Based on the evidence outlined above, the variant was classified as uncertain significance. |
Natera, |
RCV001278323 | SCV001465323 | uncertain significance | Ellis-van Creveld syndrome | 2020-08-13 | no assertion criteria provided | clinical testing |